Emmanuel Amabebe1, Steven Reynolds2, Victoria Stern1, Jennifer Parker3, Graham Stafford3, Martyn Paley2, and Dilly Anumba1
1Academic unit of Reproductive and Developmental Medicine, University of Sheffield, Sheffield, United Kingdom, 2Academic unit of Radiology, University of Sheffield, Sheffield, United Kingdom, 3School of Dentistry, University of Sheffield, Sheffield, United Kingdom
Synopsis
We characterized the metabolite profile of cervicovaginal
fluid (CVF) of a cohort of pregnant women presenting with symptoms of preterm
labor by both 1H Magnetic Resonance spectroscopy and spectrophotometric acetate
enzyme assay. Acetate normalized integral (P=0.002) and spectrophotometry (P=0.006)
were significantly higher in the women who delivered preterm compared to their
term counterparts. Both methods were
predictive of PTB <37 weeks (acetate integral: AUC=0.75, spectrophotometry:
AUC=0.74). Elevated CVF acetate in women with symptoms of preterm labor appears
predictive of preterm delivery. In these women, a clinical assay of acetate in
CVF may prove of clinical utility for predicting PTB.
Introduction: Changes in the vaginal microecology of commensal
and pathogenic organisms may influence the initiation of preterm birth (PTB),1
and can be detected in the cervicovaginal fluid (CVF) metabolite profile. We
characterized and validated the metabolite profile of CVF of a cohort of
pregnant women presenting with symptoms of preterm labor by both 1H
Magnetic Resonance spectroscopy (MRS) and spectrophotometric assay, and
determined their predictive capacity for PTB.
Methods: CVF was obtained by high-vaginal swabs from 86 pregnant
women presenting with symptoms of preterm labor (i.e. regular uterine
contractions and < 3 cm dilated cervix), but with intact membranes and no
evidence of genital infection, between 24 and 36 weeks (wks) gestation. Vaginal
secretions were dissolved in 600 µl sterile phosphate buffered saline and a 400 µl MR
sample containing 20 µl D2O was scanned with a 9.4T Bruker Avance
III MR spectrometer (Bruker BioSpin GmbH, Karlsruhe, Germany), with 5mm BBO
probe using a Watergate water suppression pulse sequence (NS = 256, D1 = 5s, AQ
= 1s, SW = 20.6 ppm, TD = 16446). Acetate and other metabolites were identified
in the MR spectrum, integrated for peak area and normalized to the total
spectrum integral (excluding water signal). Acetate concentrations (AceConc) were
also determined from a randomly selected subset of the same samples (n = 57),
by spectrophotometric absorption of NADH using acetic acid assay kit (K-ACETGK
08/14, Megazyme, IE).
Results: Acetate normalized integral (P = 0.002) and AceConc (P
= 0.006) were significantly higher in the women who delivered preterm compared
to their term counterparts (Fig. 1). The
MR derived acetate integrals were strongly correlated with the AceConc estimated
from the spectrophotometric technique (r = 0.69; P < 0.0001) (Fig. 2). Both methods were predictive of PTB < 37
wks (acetate integral: AUC = 0.75, LR+ = 4.0, LR- = 0.3; AceConc: AUC = 0.74, LR+ = 2.5, LR- = 0.4) (Fig. 3). Additionally, acetate 1H integrals
and AceConc were predictive of delivery within 2 weeks of the index assessment
(acetate integral: AUC = 0.77, LR+ = 2.0, LR- = 0.5; AceConc: AUC = 0.68, LR+ = 3.1, LR- = 0.3) with an
optimal cut-off of > 0.54 g/l (Fig. 4).
Normalized integrals of succinate, formate, lactate, glucose, glutamine/glutamate,
alanine and branched chain amino acids did not differ between term- and
preterm-delivered cohorts.
Conclusion: Elevated CVF acetate in women with symptoms of preterm
labor appears predictive of preterm delivery, as well as delivery within 2
weeks of presentation. In these women, a clinical assay of acetate in CVF may
prove of clinical utility for predicting PTB.
Acknowledgements
This study was supported
by a grant from the Medical Research Council, UK; and a PhD studentship from
the Niger Delta Development Commission and Bayelsa State Scholarship Board of Nigeria.References
1.
Witkin SS.
BJOG 2015; 122(2):213-8.